MicroRNA-200a suppresses prostate cancer progression through BRD4/AR signaling pathway

Han Guan1, Zonghao You2, Can Wang2

  • 1Department of Urology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.

Cancer Medicine
|February 21, 2019
PubMed

Insights

MicroRNA-200a (miR-200a) suppresses castration-resistant prostate cancer (CRPC) progression by targeting BRD4 and inhibiting androgen receptor signaling, offering new therapeutic avenues.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer progression to castration-resistant prostate cancer (CRPC) presents a significant clinical challenge.
  • Understanding molecular mechanisms of treatment resistance in androgen-dependent prostate cancer (ADPC) is crucial for developing new therapies.
  • The role of microRNA-200a (miR-200a) in prostate cancer pathogenesis and treatment resistance is largely unexplored.

Purpose of the Study:

  • To investigate the role and biological significance of miR-200a in prostate cancer, particularly in the context of ADPC to CRPC transition.
  • To identify molecular targets of miR-200a and elucidate its mechanism of action in suppressing CRPC progression.
  • To explore the potential of miR-200a as a therapeutic target for CRPC.

Main Methods:

  • Microarray analysis of patient datasets to assess miR-200a expression in ADPC and its association with CRPC survival.
  • In vitro studies involving miR-200a overexpression in CRPC cell lines to evaluate effects on proliferation and apoptosis.
  • In vivo xenograft models to assess the impact of miR-200a on tumor growth and metastasis.
  • Luciferase reporter assays to confirm BRD4 as a direct target of miR-200a.

Main Results:

  • miR-200a expression was elevated in ADPC and positively correlated with CRPC patient survival.
  • Overexpression of miR-200a significantly inhibited CRPC cell proliferation, induced apoptosis, and suppressed tumor growth and metastasis in vivo.
  • BRD4 was identified as a direct target of miR-200a, and its inhibition reversed miR-200a's anti-cancer effects.
  • miR-200a suppresses CRPC progression by inhibiting BRD4-mediated androgen receptor (AR) signaling.

Conclusions:

  • miR-200a plays a critical role in suppressing prostate cancer progression, particularly CRPC.
  • Targeting miR-200a or its downstream effector BRD4 presents a promising strategy for overcoming treatment resistance in CRPC.
  • These findings provide a foundation for developing personalized therapeutic approaches for CRPC patients.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.2K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.5K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
10.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.3K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.4K